Refocus Group, Inc. Share Price Other OTC
Equities
RFCS
US75865X2027
Biotechnology & Medical Research
Sales 2003 | - | Sales 2004 | - | Capitalization | 2.59M 216M |
---|---|---|---|---|---|
Net income 2003 | -5M -416M | Net income 2004 | -3M -250M | EV / Sales 2003 | - |
Net cash position 2003 | 3 249.77 | Net Debt 2004 | 0.28 23.21 | EV / Sales 2004 | - |
P/E ratio 2003 |
-1.51
x | P/E ratio 2004 |
-0.67
x | Employees | - |
Yield 2003 * |
-
| Yield 2004 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
J. Michael Judy
CEO | Chief Executive Officer | - | 28/13/28 |
David Schanzlin
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/01 |
Selene A. Burke
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 01/11/01 | |
Thomas M. Loarie
CHM | Chairman | - | 01/14/01 |
Thomas Lyles
BRD | Director/Board Member | - | 01/05/01 |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |